BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25565812)

  • 41. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isotretinoin and α-tocopherol acetate-loaded solid lipid nanoparticle topical gel for the treatment of acne.
    Gupta S; Wairkar S; Bhatt LK
    J Microencapsul; 2020 Dec; 37(8):557-565. PubMed ID: 32924680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
    Del Rosso JQ; Jitpraphai W; Bhambri S; Momin S
    Cutis; 2008 May; 81(5):405-8. PubMed ID: 18543590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients.
    Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M;
    Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.
    Kawashima M; Sato S; Furukawa F; Matsunaga K; Akamatsu H; Igarashi A; Tsunemi Y; Hayashi N; Yamamoto Y; Nagare T; Katsuramaki T
    J Dermatol; 2017 Jul; 44(7):774-782. PubMed ID: 28295516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tailoring of Retinyl Palmitate-Based Ethosomal Hydrogel as a Novel Nanoplatform for Acne Vulgaris Management: Fabrication, Optimization, and Clinical Evaluation Employing a Split-Face Comparative Study.
    Salem HF; Kharshoum RM; Awad SM; Ahmed Mostafa M; Abou-Taleb HA
    Int J Nanomedicine; 2021; 16():4251-4276. PubMed ID: 34211271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
    Warner GT; Plosker GL
    Am J Clin Dermatol; 2002; 3(5):349-60. PubMed ID: 12069641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel drug delivery systems: potential in improving topical delivery of antiacne agents.
    Date AA; Naik B; Nagarsenker MS
    Skin Pharmacol Physiol; 2006; 19(1):2-16. PubMed ID: 16247244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
    Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
    Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation optimization,
    Aldawsari MF; Khafagy ES; Moglad EH; Selim Abu Lila A
    Saudi Pharm J; 2023 Sep; 31(9):101734. PubMed ID: 37649675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
    Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
    J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride.
    Abdelbary A; Salem HF; Khallaf RA; Ali AM
    Pharm Dev Technol; 2017 May; 22(3):409-417. PubMed ID: 27476543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and comparative clinical evaluation of liposomal gel of benzoyl peroxide for acne.
    Patel VB; Misra AN; Marfatia YS
    Drug Dev Ind Pharm; 2001 Sep; 27(8):863-9. PubMed ID: 11699839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
    Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
    Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE; Mohamed EA; Khatera NAA
    Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
    Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
    Aziz DE; Abdelbary AA; Elassasy AI
    Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
    Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
    Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.